Dr. Edelman chairs Lung Cancer Foundation of America’s Scientific Advisory Board. As the chair, Dr. Edelman represents the Scientific Advisory Board at meetings of the Board of Directors.
Edelman’s achievements in oncology include developing one of the most commonly used regimens for treating advanced lung cancer and working toward the development of new agents and biomarkers to personalize lung cancer therapy. He has a particular interest in approaches that integrate surgery, radiation, and chemotherapy in the management of lung cancer patients.